John F. Kelly's most recent trade in Prestige Consumer Healthcare Inc was a trade of 2,981 Common Stock, par value $0.01 per share done . Disclosure was reported to the exchange on Aug. 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc | Mr. John F. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2026 | 2,981 | 7,832 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Prestige Consumer Healthcare Inc | Mr. John F. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2025 | 2,094 | 4,851 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Prestige Consumer Healthcare Inc | Mr. John F. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 2,202 | 2,757 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Prestige Consumer Healthcare Inc | Mr. John F. Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 555 | 555 (0%) | 0% | 0 | Common Stock, par value $0.01 per share |